Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Mott David M
Relationship:   Director
City:   Gaithersburg
State:   MD
   
Insider Summary:
  
   
Companies Owned :   36    
Direct Shares   6,113,369    

Indirect Shares

  266,283,930      
Direct Value   $10,934,548    

Indirect Value

  $996,721,744      
Total Shares   272,397,299      
Total Value   $1,007,656,292      


Ardelyx Inc
 $9,311,668 Mersana Therapeutics, Inc.
 $1,607,135 Cloudflare, Inc.
 $0 Novavax Inc
 $15,746 Enliven Therapeutics Ord Shs
 $0 Ardelyx Inc
 $9,311,668 Mersana Therapeutics, Inc.
 $1,607,135 Cloudflare, Inc.
 $0 Novavax Inc
 $15,746 Enliven Therapeutics Ord Shs
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    10   
    0    

     Stock price went up :

    4   
    0    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   23.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Medimmune Inc MEDI Vice Chairman, CEO & P... 2007-06-01 0 2003-09-15 0    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2013-06-03 575    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO Director, 10% Owner 2019-01-22 0 2019-01-22 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-09 0 2013-04-09 1,171    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM Director 2022-08-12 0 2022-08-12 0    Premium*  
            Care.com Inc CRCM 10% Owner 2014-01-29 0 2017-11-06 2,302    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX Director 2023-06-15 1,192,275 2019-12-09 6,564,372    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director, 10% Owner 0 2020-01-24 102,478,668    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2019-04-08 25,243,865    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN Director 2024-01-02 588,694 2024-01-02 9,595    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2019-05-07 2,052,454    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2017-11-20 0 2018-02-13 2,031    Premium*  
            Elastic N.v. ESTC 10% Owner 2018-10-10 0 2018-10-10 2,197,503    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2019-06-24 7,225,676    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2019-05-09 4,438,562    Premium*  
            Nightstar Therapeutics Plc NITE Director, 10% Owner 2019-06-07 0 2019-06-07 0    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2019-07-22 4,186,243    Premium*  
            Cloudflare, Inc. NET 10% Owner 2019-09-17 4,059,376 2019-09-17 0    Premium*  
            Novavax Inc NVAX Director 2023-06-10 43,800 0    Premium*  
            Enliven Therapeutics Ord Shs ELVN Director 2022-02-23 229,224 2022-02-10 0    Premium*  
* Premium Members only  

Records found :    221         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
ILIU Interleukin Genetics Inc 10% Owner   –       –       •   2013-05-17 3 IO $0.00 $0 I/I 0 15,429,122 -
ROKA Roka Bioscience, Inc. 10% Owner   –       –       •   2014-07-16 3 IO $0.00 $0 I/I 0 4,734 -
BOX Box Inc 10% Owner   –       –       •   2015-01-22 3 IO $0.00 $0 I/I 0 162,780 -
CSBR Champions Biotechnology I... 10% Owner   –       –       •   2015-03-11 3 IO $0.00 $0 I/I 0 18,750,000 -
ABIO Nuvelo Inc 10% Owner   –       –       •   2015-06-16 3 IO $0.00 $0 I/I 0 10,221,465 -
ADAP Adaptimmune Therapeutics ... Director   –       •       •   2016-01-01 3 IO $0.00 $0 I/I 0 59,269,000 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2016-05-13 3 IO $0.00 $0 I/I 0 10,362,694 -
AKAO Achaogen Inc 10% Owner   –       –       •   2016-06-03 3 IO $0.00 $0 I/I 0 4,715,128 -
CASC Cascadian Therapeutics, I... 10% Owner   –       –       •   2017-01-27 3 IO $0.00 $0 I/I 0 9,064,574 -
MULE Mulesoft, Inc 10% Owner   –       –       •   2017-03-16 3 IO $0.00 $0 I/I 0 320,780 -
RGLS Regulus Therapeutics Inc. 10% Owner   –       –       •   2017-07-24 3 IO $0.00 $0 I/I 0 10,989,010 -
NVAX Novavax Inc Director   –       •      –    2020-06-16 3 IO $0.00 $0 D/D 0 64,961 -
MEDI Medimmune Inc Vice Chairman, CEO & President   •       •      –    2007-05-25 4 GD $0.00 $0 D/D 4,743 599,355 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2011-11-21 4 A $0.00 $0 I/I 2,103,372 2,103,372 0 -
MM Millennial Media Inc 10% Owner   –       –       •   2012-04-03 4 A $0.00 $0 I/I 9,794,401 9,794,401 0 -
TSRO Tesaro, Inc. Director   –       •       •   2012-07-03 4 A $0.00 $0 I/I 10,388,144 10,388,144 0 -
TSRO Tesaro, Inc. Director   –       •       •   2012-10-15 4 A $0.00 $0 D/D 4,161 4,161 0 -
WDAY Workday, Inc. 10% Owner   –       –       •   2013-04-09 4 A $0.00 $0 I/I 24,383 1,171 0 -
WDAY Workday, Inc. 10% Owner   –       –       •   2013-04-09 4 D $0.00 $0 I/I (2,344,424) 0 0 -
WDAY Workday, Inc. 10% Owner   –       –       •   2013-04-09 4 A $0.00 $0 I/I 2,321,212 2,321,212 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-06-03 4 D $0.00 $0 I/I (1,151,289) 0 0 -
CLVS Clovis Oncology, Inc. 10% Owner   –       –       •   2013-06-03 4 A $0.00 $0 I/I 11,974 575 0 -
TSRO Tesaro, Inc. Director   –       •       •   2013-06-03 4 A $0.00 $0 D/D 1,330 5,491 0 -
TSRO Tesaro, Inc. Director   –       •       •   2013-06-04 4 D $0.00 $0 I/I (1,661,450) 0 0 -
TSRO Tesaro, Inc. Director   –       •       •   2013-06-04 4 A $0.00 $0 I/I 17,279 829 0 -

  221  Records found
  1  2   3   4   5   6   7   8   9      
  Page 1 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed